Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05265429

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.

Detailed description

This research study looks to enroll as many people diagnosed with lung cancer at 45 years old or younger in order to: * Better understand causes of lung cancer in individuals 45 years old and younger, which is a rare disease * Better estimate lung cancer risks and potential risk factors for lung cancer in individuals 45 years old and younger * Examine tumor (somatic) or normal (germline) genetic changes that may be shared among young lung cancer patients * Improve opportunities for screening and treatment of lung cancer in individuals 45 years old and younger Study procedures will include: * Collecting information from participants' medical record and two (2) short questionnaires * Collecting blood and/or saliva samples * Collecting tumor tissue samples (optional) It is expected that about 500 people will take part in this research study. Participants will be in this study until it closes or the participant withdraws consent.

Conditions

Interventions

TypeNameDescription
GENETICData and Specimen Collection* Provide research team access to relevant medical records * Answer two (2) short questionnaires at time of consent * Provide up to 5 tubes (37 ml) of blood at or near the time of consent, and/or saliva sample * Consider consenting to other optional parts of the research such as: * Providing additional blood or tissue samples in the future (optional) * Providing permission for obtainment of stored tissue specimens from lung cancer surgeries or biopsies from the pathology departments where they have been stored (optional)

Timeline

Start date
2023-01-01
Primary completion
2027-08-01
Completion
2027-08-01
First posted
2022-03-03
Last updated
2025-10-29

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05265429. Inclusion in this directory is not an endorsement.